Seroatlas · Human Serome Atlas

MDH1

Malate dehydrogenase, cytoplasmic

Also known as: MDHC_HUMAN

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
P40925
Gene
MDH1
Ensembl
ENSG00000014641
Chromosome
2
Canonical length
334 aa
Protein class
Cancer-related genes, Citric acid cycle related proteins, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins
Subcellular location
Centrosome,Cytosol
Quaternary structure
Homodimer

OverviewNCBI Gene

This gene encodes an enzyme that catalyzes the NAD/NADH-dependent, reversible oxidation of malate to oxaloacetate in many metabolic pathways, including the citric acid cycle. Two main isozymes are known to exist in eukaryotic cells: one is found in the mitochondrial matrix and the other in the cytoplasm. This gene encodes the cytosolic isozyme, which plays a key role in the malate-aspartate shuttle that allows malate to pass through the mitochondrial membrane to be transformed into oxaloacetate for further cellular processes. Alternatively spliced transcript variants have been found for this gene. A recent study showed that a C-terminally extended isoform is produced by use of an alternative in-frame translation termination codon via a stop codon readthrough mechanism, and that this isoform is localized in the peroxisomes. Pseudogenes have been identified on chromosomes X and 6. [provided by RefSeq, Feb 2016]

Canonical amino-acid sequenceUniProt

334 residues, UniProt reviewed canonical sequence.

>P40925|MDH1
     1  MSEPIRVLVT GAAGQIAYSL LYSIGNGSVF GKDQPIILVL LDITPMMGVL DGVLMELQDC
    61  ALPLLKDVIA TDKEDVAFKD LDVAILVGSM PRREGMERKD LLKANVKIFK SQGAALDKYA
   121  KKSVKVIVVG NPANTNCLTA SKSAPSIPKE NFSCLTRLDH NRAKAQIALK LGVTANDVKN
   181  VIIWGNHSST QYPDVNHAKV KLQGKEVGVY EALKDDSWLK GEFVTTVQQR GAAVIKARKL
   241  SSAMSAAKAI CDHVRDIWFG TPEGEFVSMG VISDGNSYGV PDDLLYSFPV VIKNKTWKFV
   301  EGLPINDFSR EKMDLTAKEL TEEKESAFEF LSSA

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against MDH1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Intracellular
Secreted
No
Transmembrane segments
0
Mean surface accessibility (rSASA)
0.24
Highest tissue expression
1,722 nTPM

Expression across tissuesHPA

Tissue

  • tongue: 1,722 nTPM
  • heart muscle: 1,262 nTPM
  • skeletal muscle: 742 nTPM
  • cerebral cortex: 561 nTPM
  • parathyroid gland: 386 nTPM
  • basal ganglia: 381 nTPM

Single-cell type

  • parietal cells: 1,031 nCPM
  • hofbauer cells: 596 nCPM
  • oocytes: 318 nCPM
  • extravillous trophoblasts: 306 nCPM
  • migrating cytotrophoblasts: 301 nCPM
  • cardiomyocytes: 291 nCPM

Immune cell

  • T-reg: 322 nTPM
  • total PBMC: 321 nTPM
  • basophil: 272 nTPM
  • intermediate monocyte: 268 nTPM
  • naive B-cell: 260 nTPM
  • memory B-cell: 260 nTPM

Brain region

  • cerebral cortex: 454 nTPM
  • hypothalamus: 325 nTPM
  • thalamus: 316 nTPM
  • pons: 305 nTPM
  • medulla oblongata: 299 nTPM
  • cerebellum: 291 nTPM

DiseaseUniProt · ClinVar · IEDB · PubMed

Four sources answering four different questions about MDH1.

Disease | AllUniProt

Conditions MDH1 is implicated in, by any mechanism.

Disease | GeneticClinVar

1 pathogenic / likely-pathogenic of 58 ClinVar records.

Conditions with pathogenic or likely-pathogenic variants.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
0.37
gnomAD pLI
0.93
gnomAD missense Z
1.18
DepMap mean gene effect
-0.02
DepMap dependency class
none

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads MDH1 as an antibody target. Whether an autoantibody or antibody against MDH1 could matter depends on whether native MDH1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

MDH1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.

Annotation status

The present source text does not explicitly label MDH1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/MDH1. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...